MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2025.

NCT04780256 | RECRUITING
2000 participants

Endoscopic Resection of Gastrointestinal Neoplasms

Study Type:
OBSERVATIONAL
Last Updated:
2025-10-03
Start Date:
2021-03-15
Completion:
2025-12-31
Conditions
  • Endoscopic Mucosal Resection
  • Endoscopic Submucosal Dissection
  • Gastric Neoplasm
  • Colonic Neoplasms
  • Esophageal Neoplasms
  • Duodenal Neoplasms
Interventions
  • PROCEDURE
No Results Yet
NCT04731259 | WITHDRAWN | PHASE1/PHASE2
0 participants

Study to Evaluate the Safety of ATR-04

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-03
Start Date:
2024-01-31
Completion:
2026-01-31
Conditions
  • Epidermal Growth Factor
  • Papulopustular Rosacea
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT04727047 | TERMINATED | NA
8 participants

NMES for Achilles Tendon Rupture

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-03
Start Date:
2023-02-15
Completion:
2024-12-31
Conditions
  • Achilles Tendon Rupture
Interventions
  • DEVICE
No Results Yet
NCT04631029 | COMPLETED | PHASE1
3 participants

Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-03
Start Date:
2021-04-27
Completion:
2021-12-30
Conditions
  • Extensive Stage Lung Small Cell Carcinoma
  • Malignant Solid Neoplasm
  • Metastatic Malignant Neoplasm in the Brain
Interventions
  • BIOLOGICAL
  • DRUG
Results Available
NCT04616547 | TERMINATED | PHASE2
1 participants

Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-03
Start Date:
2021-12-18
Completion:
2022-02-16
Conditions
  • Castration-Resistant Prostate Carcinoma
  • Metastatic Malignant Neoplasm in the Bone
  • Metastatic Prostate Adenocarcinoma
  • Stage IV Prostate Cancer AJCC v8
  • Stage IVA Prostate Cancer AJCC v8
  • Stage IVB Prostate Cancer AJCC v8
Interventions
  • OTHER
  • RADIATION
Results Available
NCT04458909 | TERMINATED | PHASE3
15 participants

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2025-10-03
Start Date:
2020-12-09
Completion:
2023-08-15
Conditions
  • Metastatic Nasopharyngeal Carcinoma
  • Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma
  • Metastatic Nasopharyngeal Nonkeratinizing Carcinoma
  • Metastatic Nasopharyngeal Undifferentiated Carcinoma
  • Nasopharyngeal Nonkeratinizing Carcinoma
  • Recurrent Nasopharyngeal Carcinoma
  • Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma
  • Recurrent Nasopharyngeal Undifferentiated Carcinoma
  • Stage IV Nasopharyngeal Carcinoma AJCC v8
  • Stage IVA Nasopharyngeal Carcinoma AJCC v8
  • Stage IVB Nasopharyngeal Carcinoma AJCC v8
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
Results Available
Previous
Sorted by latest updates
Next
Showing 40 trials per page